摘要
目的体外诱导非肥胖糖尿病(NOD)小鼠CD4^+CD25^+Foxp3^+调节性T细胞(Treg)的产生并检测其免疫抑制功能。探讨外源性白细胞介素(IL)-2在诱导方案中的作用。方法分选NOD小鼠童贞T细胞(NmveT),利用Anti—CD3、Anti—CD28刺激,同时给予转化生长因子-β1(TGF—B1)和白细胞介素-2(IL-2),共同培养5d,收获诱导性Treg(iTreg),经流式细胞仪检测其表型。利用体外T细胞增殖体系,对比NOD小鼠天然Treg(nTreg),评价iTreg的免疫抑制能力。将诱导方案中的IL-2撤除以观察其作用。结果TGF-β1联合IL-2能诱导NOD小鼠NaiveT转化为iTreg,较对照组有统计学意义[(41.33±3.21)%比(8.00±3.00)%,P〈0.05]。iTreg可有效抑制T细胞增殖,其能力与nTreg的差异无统计学意义[(40.33±1.03)%比(38.33±3.06),P〉0.05]。外源性IL-2有利于iTreg的产生[(41.33±3.21)%比(15.00±1.00)%,P〈0.05]。结论TGF-β1联合IL-2可在体外诱导Naive T转化为具有免疫抑制功能的Treg。
Objective To investigate the roles of TGF-β1 and IL-2 to induce the differentiation of CD^+ CD25^+Foxp3 ^+regulatory T cells from non-obese diabetic (NOD) mice and the mechanisms. Methods (1) The Naive T cells from NOD mice were stimulated by Anti-CD3 and Anti-CD28 with TGF-β1 and IL-2 for a 5-day culture. Four groups were established:control group (0 μg/L TGF-β1 ) ,low concentration group ( 1 μg/L) ,middle concentration group (5 μg/L) and high concentration group ( 10 μg/L). At the end-point of culture ,the ratio of CD4^+CD25^+Foxp3^+T cells were measured by FACS individually. (2) The CD90^+cells from NOD mice were separated by MACS and stimulated by Anti-CD3 and Anti- CD28 for establishing the proliferation system of T cells. CD4^+CD25^+T cells were isolated by MACS and added into the proliferation system to measure the immunosuppressive activity of these cells. Meanwhile the role of IL-2 in this protocol was studied. Results TGF-β1 combined with IL-2 could convert Naive T cells from NOD mice to iTreg which could suppress the proliferation of T cells [ (41.33 ± 3.21 ) % vs ( 8.00 ± 3.00)% ,P 〈 0.05]. 5 μg/L TGF-β1 was an effective dose which could increase the ratio of CD4^+CD25^+Foxp3^+Treg cells. IL-2 was essential in this protocol [ (41.33 ± 3.21 ) % vs ( 15.00 ± 1.00) %, P〈0.05].Conclusion TGF-β1 combined with IL-2 induced CD4^+CD25^+Foxp3^+Treg from Naive T cells,which could suppress the proliferation of T cells.
出处
《中华实验外科杂志》
CAS
CSCD
北大核心
2008年第1期45-47,共3页
Chinese Journal of Experimental Surgery
基金
国家自然科学基金资助项目(30671002)